| DC Field | Value | Language |
|---|
| dc.contributor.author | Kolesnichenko, P. D. | - |
| dc.contributor.author | Soldatov, V. O. | - |
| dc.contributor.author | Puchenkova, O. A. | - |
| dc.contributor.author | Dudchenko, O. V. | - |
| dc.contributor.author | Miller, E. S. | - |
| dc.date.accessioned | 2020-06-06T19:37:49Z | - |
| dc.date.available | 2020-06-06T19:37:49Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Potentiating interaction of ethoxydol and rosuvastatin in an experimental model of Langendorf-isolated rat heart total ischemia-reperfusion / P. D. Kolesnichenko, V. O. Soldatov, O. A. Puchenkova [et al.] // Asian Journal of Pharmaceutics. - 2018. - Vol.12, suppl.4. – P. S1335-S1338. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/31538 | - |
| dc.description.abstract | The study of cardioprotective activity showed that in vitro ethoxydol at a dose of 3.8 × 10-4 g/l can significantly improve the morphofunctional state of cardiomyocytes, which is manifested in an increase in the proportion of postischemic cardiac resumption, reduction of ischemic contracture, and recovery of contractility during the reperfusion period | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacy | ru |
| dc.subject | Ethoxydol | ru |
| dc.subject | Rosuvastatin | ru |
| dc.subject | Langendorf-isolated | ru |
| dc.subject | ischemia-reperfusion | ru |
| dc.subject | myocardiocytes | ru |
| dc.title | Potentiating interaction of ethoxydol and rosuvastatin in an experimental model of Langendorf-isolated rat heart total ischemia-reperfusion | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
